Tuberculosis drug discovery: challenges and new horizons

GFS Fernandes, AM Thompson… - Journal of Medicinal …, 2022 - ACS Publications
Over the past 2000 years, tuberculosis (TB) has claimed more lives than any other infectious
disease. In 2020 alone, TB was responsible for 1.5 million deaths worldwide, comparable to …

Design and synthesis of novel antimicrobial agents

Z Breijyeh, R Karaman - Antibiotics, 2023 - mdpi.com
The necessity for the discovery of innovative antimicrobials to treat life-threatening diseases
has increased as multidrug-resistant bacteria has spread. Due to antibiotics' availability over …

[HTML][HTML] Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents

NG Bajad, SK Singh, SK Singh, TD Singh… - Current Research in …, 2022 - Elsevier
Indole-containing small molecules have been reported to have diverse pharmacological
activities. The aromatic heterocyclic scaffold, which resembles various protein structures …

Fragment-based drug discovery against mycobacteria: the success and challenges

NS Togre, AM Vargas, G Bhargavi… - International Journal of …, 2022 - mdpi.com
The emergence of drug-resistant mycobacteria, including Mycobacterium tuberculosis (Mtb)
and non-tuberculous mycobacteria (NTM), poses an increasing global threat that urgently …

Enhanced Hemolytic Activity of Mesophilic Aeromonas salmonicida SRW-OG1 Is Brought about by Elevated Temperatures

Y Chen, J Wang, H Cai, M Lin, Y Zhang, L Huang - Microorganisms, 2022 - mdpi.com
Aeromonas salmonicida is a well-known cold-water pathogenic bacterium. Previously, we
reported the first isolation of pathogenic A. salmonicida from diseased Epinephelus …

In silico drug design strategies for discovering novel tuberculosis therapeutics

CSC Canales, AR Pavan, JL Dos Santos… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Tuberculosis remains a significant concern in global public health due to its
intricate biology and propensity for developing antibiotic resistance. Discovering new drugs …

Identification of diphenyl furan derivatives via high throughput and computational studies as ArgA inhibitors of Mycobacterium tuberculosis

H Khurana, M Srivastava, D Chaudhary… - International Journal of …, 2021 - Elsevier
Microbial amino acid biosynthetic pathways are underexploited for the development of anti-
bacterial agents. N-acetyl glutamate synthase (ArgA) catalyses the first committed step in L …

[HTML][HTML] ArgD of Mycobacterium tuberculosis is a functional N-acetylornithine aminotransferase with moonlighting function as an effective immune modulator

IB Nehvi, N Quadir, M Khubaib, JA Sheikh… - International Journal of …, 2022 - Elsevier
Mycobacterium tuberculosis (M. tuberculosis) encodes an essential enzyme acetyl ornithine
aminotransferase ArgD (Rv1655) of arginine biosynthetic pathway which plays crucial role …

Kinetic Characterization and Catalytic Mechanism of N-Acetylornithine Aminotransferase Encoded by slr1022 Gene from Synechocystis sp. PCC6803

ZM Li, F Bai, X Wang, C Xie, Y Wan, Y Li, J Liu… - International journal of …, 2023 - mdpi.com
The enzyme encoded by slr1022 gene from Synechocystis sp. PCC6803 was reported to
function as N-acetylornithine aminotransferase, γ-aminobutyric acid aminotransferase, and …

[PDF][PDF] De novo design of novel spike glycoprotein inhibitors using e-pharmacophore modeling, molecular hybridization, ADMET, quantum mechanics and molecular …

AA Alzain, A Ismail, M Fadlelmola… - Pakistan Journal of …, 2022 - researchgate.net
The pandemic COVID-19, caused by SARS-COV-2, has been a global concern and burden
since April 2020 due to high contagiousness and pathogenesis. A great effort is being …